Source: Pharmabiz

AlloSource: AlloSource introduces AceConnex, first presutured fascia device for hip labral reconstruction and augmentation

AlloSource, one of the largest allograft providers creating innovative cellular and tissue products to help surgeons heal their patients, announced the launch of its AceConnex pre─sutured fascia device.

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
250-500
Dean Elliott's photo - President & CEO of AlloSource

President & CEO

Dean Elliott

CEO Approval Rating

82/100

Read more